RE:I wonder....No 2 is done, so most likely No 1 will be announced shortly.
francoisl13 wrote: ...if KNE set the expectations to high (again) for Q4...here's what they are targeting for Q4/2024 (from their September presentation):
1. Financing announcement
2. Potential M&A announcement
3. Announce distribution agreements outside of North America - (done for some part of the world)
4.Obtain clearance from Health Canada on revyve Antimicrobial Wound Gel - (didn't see any official announcement)
5.Launch revyve Antimicrobial Wound Gel Spray
6.Commence DispersinB University of Miami Clinical Trial
It is Nov.5th...I wonder if any of the above will happen in Q4 considering that we're basically left with only 5-6 weeks before the Holidays and very little of the above have been confirmed and announced.
I understand that KNE is in a highly supervised and reglemented market but, setting up the expectations and then not meeting them is not doing any good to the company reputation especially with the investment community.
As I said many times, I like this company product lines and the way they are managing it but, not their 'bat average' in regards to meeting expectations they are setting up themself...
GLTA!